Clinical application of conservative rectal surgery after neoadjuvant therapy for low locally advanced rectal cancer

Phase 1

• Conditions: low rectal cancer

• Registration Number: ITMCTR1900002450
• Lead Sponsor: The Affiliated Nanjing Hospital of Nanjing University of Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1. Those aged between 30 and 80 years;
2. ERUS, MR, CT and pathological biopsy were performed before operation, and the clinical staging was consistent with low locally advanced rectal cancer.
3. Agree to accept preoperative neoadjuvant therapy plus rectal conservative surgery.

Exclusion Criteria

Family history of colorectal cancer.

Study & Design

• Study Type: Observational study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Distant metastasis rate within 2 years;5-year survival rate;Local recurrence rate within 2 years;

Secondary Outcome Measures

Name	Time	Method
Ratio of R0 resection;Anal function;Oncological indicators;Urination functions;Incidence of complications;